alpha-hydroxyglutarate has been researched along with Bile Duct Obstruction in 1 studies
2-hydroxyglutarate : A dicarboxylic acid anion obtained by deprotonation of at least one of the carboxy groups of 2-hydroxyglutaric acid.
2-hydroxyglutaric acid : A 2-hydroxydicarboxylic acid that is glutaric acid in which one hydrogen alpha- to a carboxylic acid group is substituted by a hydroxy group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Tian, X | 3 |
Wang, Y | 3 |
Lu, Y | 3 |
Wu, B | 3 |
Chen, S | 3 |
Du, J | 3 |
Cai, W | 3 |
Xiao, Y | 3 |
1 other study available for alpha-hydroxyglutarate and Bile Duct Obstruction
Article | Year |
---|---|
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling.
Topics: Animals; Biliary Atresia; Cholestasis; Liver; Mammals; Mice; Sirolimus; TOR Serine-Threonine Kinases | 2022 |